Skip to main content
TipRanks
Go Ultimate75% OFF

BeOne Medicines (49BA) Q4 2023 Earnings Report

4 Followers

DE:49BA Q4 2023 EPS Results

Actual EPS
-EUR 3.20
Consensus EPS
-EUR 3.17
Beat/Miss
Missed by -EUR 0.04
One Year Ago EPS
-EUR 3.89

DE:49BA Q4 2023 Revenue Results

Actual Revenue
EUR 579.55M
Expected Revenue
EUR 577.87M
Beat/Miss
Beat by +EUR 1.69M
YoY Revenue Growth
+68.37%

Earnings Announcement Details

Quarter
Q4 2023
Date
03/28/2024
Time
Before Open
Conference Call
Thursday, March 28, 2024
DE:49BA Upcoming Earnings

BeOne Medicines's next earnings date is estimated for March 31, 2027, based on past reporting schedules.

Q4 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:49BA Earnings History

DE:49BA earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 31, 20272026 (Q4)2.34-0.54――
Nov 05, 20262026 (Q3)1.722.950.99198.17% (+1.96)
Aug 05, 20262026 (Q2)1.511.860.83125.27% (+1.03)
May 06, 20262026 (Q1)0.881.780―
Feb 26, 20262025 (Q4)1.130.54-1.3141.96% (+1.84)
Nov 06, 20252025 (Q3)0.770.99-1.04194.78% (+2.03)
Aug 06, 20252025 (Q2)0.350.83-1.04179.13% (+1.87)
May 07, 20252025 (Q1)-0.520.00-2.19100.00% (+2.19)
Feb 27, 20252024 (Q4)-0.92-1.30-3.259.49% (+1.91)
Nov 12, 20242024 (Q3)-1.01-1.041.82-157.21% (-2.87)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed